Cargando…

Effect of post-consolidation regimen on symptomatic osteonecrosis in three DCOG acute lymphoblastic leukemia protocols

Detalles Bibliográficos
Autores principales:	van Atteveld, Jenneke E., de Groot-Kruseman, Hester A., Fiocco, Marta, Lequin, Maarten H., Neggers, Sebastian J.C.M.M., Pluijm, Saskia M.F., van der Sluis, Inge M., Pieters, Rob, van den Heuvel-Eibrink, Marry M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2021
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018109/ https://www.ncbi.nlm.nih.gov/pubmed/32646890 http://dx.doi.org/10.3324/haematol.2020.257550

Ejemplares similares

Recent perspectives on the association between osteonecrosis and bone mineral density decline in childhood acute lymphoblastic leukemia
por: van Atteveld, Jenneke E, et al.
Publicado: (2021)

Influence of bisphosphonates or recombinant human parathyroid hormone on in vitro sensitivity of acute lymphoblastic leukemia cells to chemotherapy
por: de Winter, Demi T.C., et al.
Publicado: (2022)

Vitamin D supplementation for children with cancer: A systematic review and consensus recommendations
por: van Atteveld, Jenneke E., et al.
Publicado: (2021)

Dexamethasone-Induced Sarcopenia and Physical Frailty in Children With Acute Lymphoblastic Leukemia: Protocol for a Prospective Cohort Study
por: Verwaaijen, Emma Jacobine, et al.
Publicado: (2022)

Risk and Temporal Changes of Heart Failure Among 5‐Year Childhood Cancer Survivors: a DCOG‐LATER Study
por: Feijen, E. A. M. (Lieke), et al.
Publicado: (2018)

Pregnancy, time to pregnancy and obstetric outcomes among female childhood cancer survivors: results of the DCOG LATER-VEVO study
por: van Dijk, M., et al.
Publicado: (2020)

Venous thromboembolism in a large cohort of children with acute lymphoblastic leukemia: Risk factors and effect on prognosis
por: Klaassen, Irene L. M., et al.
Publicado: (2019)

Venous Thrombosis in Children with Acute Lymphoblastic Leukemia Treated on DCOG ALL-9 and ALL-10 Protocols: The Effect of Fresh Frozen Plasma
por: Klaassen, Irene L. M., et al.
Publicado: (2019)

P366: ARE MINIMAL RESIDUAL DISEASE MEASUREMENTS AFTER CONSOLIDATION THERAPY USEFUL IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA?
por: Stutterheim, Janine, et al.
Publicado: (2023)

Changes in intracellular folate metabolism during high-dose methotrexate and Leucovorin rescue therapy in children with acute lymphoblastic leukemia
por: Oosterom, Natanja, et al.
Publicado: (2019)

The evaluation of red blood cell folate and methotrexate levels during protocol M in childhood acute lymphoblastic leukemia
por: Oosterom, N., et al.
Publicado: (2020)

Abdominal Radiotherapy: A Major Determinant of Metabolic Syndrome in Nephroblastoma and Neuroblastoma Survivors
por: van Waas, Marjolein, et al.
Publicado: (2012)

S112: THE EFFECT OF IMMUNOGLOBULIN PROPHYLAXIS ON INFECTIOUS MORBIDITY IN PEDIATRIC PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA: RESULTS OF A RANDOMIZED CONTROLLED TRIAL
por: Thus, Kirsten, et al.
Publicado: (2023)

The utility of a portable muscle ultrasound in the assessment of muscle alterations in children with acute lymphoblastic leukaemia
por: Verwaaijen, Emma J., et al.
Publicado: (2023)

Novel Adaption of the SARC-F Score to Classify Pediatric Hemato-Oncology Patients with Functional Sarcopenia
por: Verwaaijen, Emma J., et al.
Publicado: (2023)

Unraveling Dexamethasone-Induced Neurobehavioral and Sleep Problems in Children With ALL: Which Determinants Are Important?
por: van Hulst, Annelienke M., et al.
Publicado: (2023)

Progress against childhood and adolescent acute lymphoblastic leukaemia in the Netherlands, 1990–2015
por: Reedijk, Ardine M. J., et al.
Publicado: (2020)

MON-096 Body Composition in Patients with Craniopharyngioma: Is DXA-Scanning Necessary for Evaluating the Metabolic Syndrome?
por: van Santen, Selveta, et al.
Publicado: (2019)

Metabolic Syndrome Parameters, Determinants, and Biomarkers in Adult Survivors of Childhood Cancer: Protocol for the Dutch Childhood Cancer Survivor Study on Metabolic Syndrome (Dutch LATER METS)
por: Pluimakers, Vincent, et al.
Publicado: (2021)

Can biomarkers be used to improve diagnosis and prediction of metabolic syndrome in childhood cancer survivors? A systematic review
por: Pluimakers, Vincent G., et al.
Publicado: (2021)

A decrease in vitamin D levels is associated with methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia
por: Oosterom, N., et al.
Publicado: (2018)

Study protocol: DexaDays-2, hydrocortisone for treatment of dexamethasone-induced neurobehavioral side effects in pediatric leukemia patients: a double-blind placebo controlled randomized intervention study with cross-over design
por: van Hulst, A. M., et al.
Publicado: (2021)

Obesity Is Underestimated Using Body Mass Index and Waist-Hip Ratio in Long-Term Adult Survivors of Childhood Cancer
por: Blijdorp, Karin, et al.
Publicado: (2012)

Global methylation in relation to methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia
por: Oosterom, Natanja, et al.
Publicado: (2018)

Acute Activation of Metabolic Syndrome Components in Pediatric Acute Lymphoblastic Leukemia Patients Treated with Dexamethasone
por: Warris, Lidewij T., et al.
Publicado: (2016)

Experiences of Female Childhood Cancer Patients and Survivors Regarding Information and Counselling on Gonadotoxicity Risk and Fertility Preservation at Diagnosis: A Systematic Review
por: Clasen, Nikita H. Z., et al.
Publicado: (2023)

Risk factors for steroid‐induced adverse psychological reactions and sleep problems in pediatric acute lymphoblastic leukemia: A systematic review
por: van Hulst, Annelienke M., et al.
Publicado: (2021)

Is asparaginase encapsulated in erythrocytes effective as second‐line treatment in acute lymphoblastic leukaemia?
por: van der Sluis, Inge M., et al.
Publicado: (2022)

P1077: RISK OF IMPAIRED OVARIAN RESERVE AND ADVERSE PREGNANCY OUTCOMES AFTER TREATMENT FOR CHILDHOOD HODGKIN LYMPHOMA; THE DCOG LATER-VEVO STUDY.
por: Drechsel, Katja, et al.
Publicado: (2023)

Patient-derived oral mucosa organoids as an in vitro model for methotrexate induced toxicity in pediatric acute lymphoblastic leukemia
por: Driehuis, E., et al.
Publicado: (2020)

Correction: Patient-derived oral mucosa organoids as an in vitro model for methotrexate induced toxicity in pediatric acute lymphoblastic leukemia
por: Driehuis, E., et al.
Publicado: (2020)

Fractures, Bone Mineral Density, and Final Height in Craniopharyngioma Patients with a Follow-up of 16 Years
por: van Santen, Selveta S, et al.
Publicado: (2020)

Upfront Treatment Influences the Composition of Genetic Alterations in Relapsed Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia
por: Yu, Jiangyan, et al.
Publicado: (2020)

A Study on Prevalence and Determinants of Ototoxicity During Treatment of Childhood Cancer (SOUND): Protocol for a Prospective Study
por: Diepstraten, Franciscus A, et al.
Publicado: (2022)

Subtype prediction in pediatric acute myeloid leukemia: classification using differential network rank conservation revisited
por: Obulkasim, Askar, et al.
Publicado: (2015)

Identifying the critically ill paediatric oncology patient: a study protocol for a prospective observational cohort study for validation of a modified Bedside Paediatric Early Warning System score in hospitalised paediatric oncology patients
por: Soeteman, Marijn, et al.
Publicado: (2021)

Elevated Mutational Age in Blood of Children Treated for Cancer Contributes to Therapy-Related Myeloid Neoplasms
por: Bertrums, Eline J.M., et al.
Publicado: (2022)

Nutritional Preconditioning in Cancer Treatment in Relation to DNA Damage and Aging
por: van den Boogaard, Winnie M.C., et al.
Publicado: (2021)

Tyrosine kinase fusion genes in pediatric BCR-ABL1-like acute lymphoblastic leukemia
por: Boer, Judith M., et al.
Publicado: (2016)

Hypopituitarism after subarachnoid haemorrhage, do we know enough?
por: Khajeh, Ladbon, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_47i6ttr68i65cgu8ig05rp18hv